ARTICLE
22 January 2008

CMS Delays Anti-Markup Rule With Respect To Purchased Interpretations And Other Services

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
On December 28, 2007, the Centers for Medicare and Medicaid Services (CMS) issued a final rule that delays the applicability of certain important revisions to the anti-markup rule as revised by the 2008 Medicare Physician Fee Schedule (MPFS). Medicare regulations currently prohibit the markup of the technical component of certain diagnostic tests that are performed by outside suppliers and billed to Medicare by a different individual or entity.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On December 28, 2007, the Centers for Medicare and Medicaid Services (CMS) issued a final rule that delays the applicability of certain important revisions to the "anti-markup" rule as revised by the 2008 Medicare Physician Fee Schedule (MPFS). Medicare regulations currently prohibit the markup of the technical component of certain diagnostic tests that are performed by outside suppliers and billed to Medicare by a different individual or entity.

Among the significant changes to the anti-markup provisions in the MPFS are: (1) the extension of anti-markup principles to purchased interpretations (as opposed to just purchased technical components); and (2) the principle that a physician/supplier cannot mark up the cost of a test, even if performed by his or her own employees in a building that fully meets the "Stark Law" requirements, but is not performed in the "office of the billing physician or other supplier."

Specifically, the CMS has now delayed the anti-markup rule's applicability until January 1, 2009, except with respect to the technical component of a purchased diagnostic test and to any anatomic pathology diagnostic testing services furnished in space that: (1) is utilized by a physician group practice as a "centralized building" for purposes of complying with the Stark rules; and (2) does not qualify as a "same building."

This delay avoids the potentially serious operational disruptions that would have resulted from implementation of these regulatory changes. This delay is useful for the industry to digest the proposed requirements and provide further commentary to the CMS.

The Final Rule including the delay was published on January 3, 2008, in the Federal Register (73 Fed. Reg. 404). The MPFS can be located at: https://www.cms.hhs.gov/PhysicianFeeSched/downloads/CMS-1385-FC.pdf.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More